On Demand

Axitinib case study: integrated modality treatment for mRCC

Dr Kate Fife

For prescribing information and adverse event reporting please see the link in the information panel on the RHS of this page.

This case study highlights the importance of intra- and inter-patient variability and of dose individualization with axitinib to achieve disease control and maintain quality of life. It also addresses how challenging local mRCC may be managed using a multimodality approach of TKIs, radiotherapy and surgery.